EMA Approval Process

The EMA (European Medicines Agency) is the regulatory body responsible for approving human and veterinary medicines across European Union member states. The approval process requires pharmaceutical companies to submit comprehensive dossiers demonstrating safety, efficacy, and quality. These dossiers contain preclinical studies (lab and animal tests), clinical trial results (human testing), manufacturing information, and risk management plans. The EMA operates multiple review pathways. The centralized procedure is fastest: a single EMA committee reviews globally and issues one approval valid across all EU countries. Decentralized and mutual recognition procedures involve multiple national regulators and take longer. Once approved, companies must maintain compliance, report adverse events, and update safety data annually.